Clinical Trials Browser

Withdrawn × Prostatic Neoplasms × Mitoxantrone × Clear all

NCT00003858 2016-07-13

Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence

Phase 2 Withdrawn

Prostatic Neoplasms